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The intralumenal fragment pathway mediates
ESCRT-independent surface transporter
down-regulation
Erin Kate McNally1 & Christopher Leonard Brett1
Surface receptor and transporter protein down-regulation is assumed to be exclusively
mediated by the canonical multivesicular body (MVB) pathway and ESCRTs (Endosomal
Sorting Complexes Required for Transport). However, few surface proteins are known to
require ESCRTs for down-regulation, and reports of ESCRT-independent degradation are
emerging, suggesting that alternative pathways exist. Here, using Saccharomyces cerevisiae as
a model, we show that the hexose transporter Hxt3 does not require ESCRTs for down-
regulation conferring resistance to 2-deoxyglucose. This is consistent with GFP-tagged Hxt3
bypassing ESCRT-mediated entry into intralumenal vesicles at endosomes. Instead, Hxt3-GFP
accumulates on vacuolar lysosome membranes and is sorted into an area that, upon fusion, is
internalized as an intralumenal fragment (ILF) and degraded. Moreover, heat stress or
cycloheximide trigger degradation of Hxt3-GFP and other surface transporter proteins (Itr1,
Aqr1) by this ESCRT-independent process. How this ILF pathway compares to the MVB
pathway and potentially contributes to physiology is discussed.
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Surface polytopic proteins including receptors, transporters,and channels are internalized and sent to lysosomes fordegradation1–3. Precise control of their surface levels
underlies diverse physiology, including endocrine function,
wound healing, tissue development, nutrient absorption, and
synaptic plasticity2,4–11. Damaged surface proteins are also
cleared by this mechanism to prevent proteotoxicity12–14. To
trigger this process, surface proteins are labeled with ubiquitin—
in response to changing substrate levels, heat stress to induce
protein misfolding or cellular signaling for example—and then
selectively internalized by the process of endocytosis13,15–20.
Within the cell, they are sent to endosomes where they encounter
ESCRTs (endosomal sorting complexes required for transport).
These ﬁve protein complexes (ESCRT-0, -I, -II, -III, and the Vps4
complex) sort and package these internalized surface proteins
into IntraLumenal Vesicles (ILVs)3. After many rounds, ILVs
accumulate creating a mature multivesicular body (MVB)21,22.
The MVB then fuses with lysosomes to expose protein laden ILVs
to lumenal hydrolases for catabolism2.
Although many examples of ESCRT-mediated protein degra-
dation have been published20, reports of ESCRT-independent
degradation of surface proteins are emerging23–27. Furthermore,
ILVs can be formed independent of ESCRT function and proteins
recognized by ESCRTs continue to be degraded when ESCRTs are
impaired28–31. These realizations have led to one of the most
prominent open questions in our ﬁeld: What accounts for
ESCRT-independent ILV formation and surface protein
degradation?
Around the time when ESCRTs were discovered32, Wickner,
Merz and colleagues reported that an ILV-like structure called an
intralumenal fragment (ILF) is formed as a byproduct of homo-
typic vacuolar lysosome (or vacuole) fusion in the model
organism Saccharomyces cerevisiae33. Prior to lipid bilayer mer-
ger, fusogenic proteins and lipids concentrate within a ring at the
vertex between apposing vacuole membranes34,35. Upon SNARE
(Soluble NSF [N-ethylmaleimide-sensitive factor] Associated
protein REceptor)-mediated membrane fusion at the vertex ring,
the encircled area of membrane, called the boundary, is excised
and internalized within the lumen of the fusion product where it
encounters acid hydrolases36.
We recently discovered that vacuolar polytopic proteins, e.g.,
ion and nutrient transporters, are selectively sorted into the
boundary membrane for degradation in response to substrate
levels, misfolding by heat stress or TOR (Target Of Rapamycin)
signaling triggered by cycloheximide37. Named the ILF pathway,
this process functions independently of ESCRTs and instead
relies on the fusion protein machinery for transporter sorting
and ILF formation. This process performs similar functions as
ESCRTs, except the mechanisms underlying protein sorting and
packaging are distinct. Thus, the possibility exists that surface
polytopic proteins may also be degraded by the ILF pathway if
they can be delivered to the vacuole membrane after
internalization.
Can internalized surface proteins be delivered to vacuole
membranes? To our knowledge, this hypothesis has not been
formally tested. However, this proposition seems reasonable when
considering the consequence of bypassing ESCRT function in the
canonical MVB pathway (Fig. 1a). In theory, any internalized
surface polytopic protein that is not packaged into ILVs by
ESCRTs (or returned to the surface) remains embedded within
the outer membrane of the mature MVB. When this membrane
merges with the vacuole membrane upon heterotypic fusion,
these proteins are then exposed to the ILF machinery, which may
package them for degradation. Thus, by simply avoiding recog-
nition by ESCRTs, internalized surface proteins are, by default,
delivered to vacuole membranes and the ILF pathway.
Upon reexamination of micrographs presented in earlier
reports on receptor and transporter down-regulation, we found
that some internalized surface polytopic proteins appear on
vacuole membranes on route to the lumen for degradation, e.g.,
the high-afﬁnity tryptophan permease Tat238, peptide transporter
Ptr239, myo-inositol transporter Itr140, and glucose transporters
Hxt1 and Hxt341. We also noticed that most of these published
studies do not directly assess whether ESCRTs are required for
protein degradation. Given that internalized surface transporters
and receptors can appear on vacuole membranes, we decided to
test the hypothesis that the ILF pathway represents an alternative,
ESCRT-independent mechanism for degradation of surface
polytopic proteins (Fig. 1a).
Results
ESCRTs are not required for 2-deoxyglucose resistance.
ESCRTs have been implicated in the down-regulation of surface
transporters required for S. cerevisiae cell survival and prolifera-
tion in the presence of toxic substrates. For example, to prevent
entry of the toxic arginine analog canavanine, the surface arginine
permease Can1 is endocytosed and sorted for degradation by
ESCRTs17. Similarly, the surface glucose transporter Hxt3 is
internalized and degraded in the presence of 2-deoxyglucose, a
toxic glucose analog41. It has been proposed that deleting ESCRTs
blocks delivery to vacuoles and subsequent degradation of these
transporters, causing them to accumulate in aberrant endosomal
structures. Here they can be returned to the plasma membrane by
a Snx3-dependent retrograde trafﬁcking pathway, allowing toxin
entry17. Thus, based on this model, deletion of ESCRT genes
should reduce cell viability in the presence of canavanine or 2-
deoxyglucose.
We tested this hypothesis by treating yeast cultures with
increasing concentrations of either toxin and then assessed effects
on cell viability by imaging and counting dead yeast cells stained
with methylene blue (Fig. 1b). As expected, deleting components
of ESCRT-0 (VPS27) or ESCRT-II (VPS36)—to disrupt different
early- or late-acting complexes, respectively, necessary for protein
sorting into ILVs—enhanced sensitivity to the toxin canavanine.
However, deleting these ESCRT genes had no effect on cell
viability in the presence of 2-deoxyglucose. As controls, we
examined cells lacking CAN1 or HXT3 and found that they were
resistant to canavanine or 2-deoxyglucose, respectively, as
predicted. Thus, these data suggest that ESCRTs mediate
degradation of Can1 but may not be required for Hxt3
degradation triggered by 2-deoxyglucose.
Hxt3 protein degradation is ESCRT-independent. Based on
micrographs presented in previous reports showing Hxt3 on
vacuole membranes41, we ﬁrst assessed the possibility that
internalized Hxt3 bypassed ESCRTs altogether at the endo-
some and instead were delivered to vacuole membranes where
it may be sorted for degradation. To test this hypothesis, we
used ﬂuorescence microscopy to monitor the distribution of
GFP-tagged Hxt3 in live S. cerevisiae cells over time after
addition of 2-deoxyglucose (Fig. 1c). As predicted, Hxt3-GFP is
exclusively found on the plasma membrane before treatment.
After addition of 2-deoxyglucose, it ﬁrst appears on puncta
(representing endosomes; at 5 min) and later on vacuole
membranes stained with FM4–64 (30 min; Fig. 1d). Finally,
Hxt3-GFP accumulates within the vacuole 60–120 min after
treatment. We assessed all cells imaged, quantiﬁed these
observations (Fig. 1e) and conﬁrmed that Hxt3-GFP was pro-
gressively cleared from the plasma membrane while accumu-
lating in puncta, on the vacuole membrane and in the vacuole
lumen over time after 2-deoxyglucose addition. In contrast,
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-07734-5
2 NATURE COMMUNICATIONS |          (2018) 9:5358 | https://doi.org/10.1038/s41467-018-07734-5 | www.nature.com/naturecommunications
internalized Can1-GFP, an ESCRT-client, never appears on
vacuole membranes on route to the vacuole lumen for degra-
dation when cells were treated with canavanine (Fig. 1c–e), as
predicted for the canonical MVB pathway. To conﬁrm that
proteolysis occurs, we conducted western blot analysis to detect
cleavage of GFP from Hxt3 or Can1 in whole-cell lysates
(Fig. 1f). As predicted, we found that more GFP was cleaved
over time correlating with toxin triggered downregulation of
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In all, these ﬁndings suggest that internalized Hxt3-GFP
bypasses ESCRT function at endosomes, and instead is delivered
to vacuole membranes on route to the lumen where it is degraded
in response to 2-deoxyglucose. If true, then deleting ESCRT genes
should have no effect on this process. To test this hypothesis, we
tracked the subcellular distribution of Hxt3-GFP after 2-
deoxyglucose treatment in cells lacking the ESCRT gene VPS36
(Fig. 1c–e). Although Hxt3-GFP continues to be delivered to the
vacuole lumen over time, we noticed that on route, Hxt3-GFP
abnormally accumulated on puncta and vacuole membranes,
even prior to treatment, in mutant cells. This is consistent with
previous reports showing that deleting ESCRT genes impairs, but
does not entirely block, endocytosis and delivery of vacuole cargo
proteins in addition to completely abolishing protein sorting into
ILVs3. Importantly, GFP continued to be cleaved from Hxt3
(Fig. 1f) conﬁrming that it continues to be degraded in absence of
VPS36. Thus, delivery of internalized Hxt3-GFP to the vacuole
lumen for degradation in response to 2-deoxyglucose does not
require ESCRTs.
2-deoxyglucose triggers Hxt3 degradation by ILF pathway.
What mediates ESCRT-independent Hxt3-GFP degradation?
Because this surface polytopic proteins appear on the vacuole
membrane, we reasoned that this is where it is sorted and
packaged into intralumenal vesicles or fragments for degradation.
Although microautophagy may be responsible, no intermediate
structures resembling elongated invaginations extending into the
vacuole lumen were observed42 and there are no reports of
selective protein sorting associated with this process (rather these
structures seem to be devoid of membrane proteins42). Instead,
we considered two processes reported to mediate selective
degradation of vacuole membrane proteins: the ESCRT-
dependent vReD (vacuole membrane Recycling and Degrada-
tion) pathway43 and ESCRT-independent ILF pathway37. Given
that ESCRTs were not required for Hxt3-GFP down-regulation,
we eliminated the possibility that the vReD pathway was
responsible and focused on the ILF pathway.
Upon further examination of micrographs showing Hxt3-GFP
distributed on vacuole membranes after toxin addition, we found
that it was present within boundary membranes between docked
vacuoles, the area of membrane that is internalized as an ILF and
degraded upon fusion (Fig. 2a, b). To conﬁrm, we measured the
GFP ﬂuorescence within the vacuole boundary membranes in the
cell population (Fig. 2c). To determine if Hxt3-GFP was getting
sorted into the boundary, we compared its distribution to three
GFP-tagged ILF-client proteins that are residents of the vacuole
membrane: Fet5 (a copper oxidase) which is known to be
excluded from boundaries, Vph1 (the stalk domain of the V-type
H+-ATPase) which is distributed uniformly on vacuole mem-
branes, and Fth1 (an iron transporter) which is enriched in
boundaries (Fig. 2b–d; see ref. 37). From this analysis, it was clear
that the Hxt3-GFP boundary proﬁle was most similar to Fth1-
GFP (Fig. 2b, c), suggesting that it was enriched and thus possibly
sorted into the ILF pathway.
We also found that the distribution of these three GFP-tagged
resident vacuole proteins was unaffected by 2-deoxyglucose
(Fig. 2d), suggesting that their turnover was not stimulated by
this toxin. Similarly, 2-deoxyglucose does not trigger down-
regulation of GFP-tagged Can1 or the surface myo-inositol
transporter Itr1 (Fig. 2d). Moreover, Hxt3-GFP was not down-
regulated when cells were treated with canavanine (Fig. 2a). We
assessed all cells imaged, quantiﬁed these observations and
conﬁrmed that only Hxt3-GFP was downregulated by 2-
deoxyglucose but it was unaffected by canavanine (Fig. 2e).
These important ﬁndings imply that Hxt3-GFP was selectively
sorted into the ILF pathway in response to only its cognate toxic
substrate 2-deoxyglucose.
Finally, to demonstrate that Hxt3-GFP was internalized into
the lumen during fusion we recorded homotypic vacuole
membrane fusion events in live cells treated with 2-deoxyglucose,
and conﬁrmed that Hxt3-GFP decorated ILFs created by fusion
events (Fig. 2f; Supplementary Movie 1). Homotypic vacuole
fusion was not stimulated by 2-deoxyglucose, as we counted the
same number of fusion events within cells in the absence (CTL)
and presence of the toxin (Fig. 2g). Thus, vacuole fusion persists
under these conditions and seems to mediate the selective
degradation of Hxt3 after endocytosis.
Together, these observations led us to conclude that Hxt3
avoids ESCRTs and is instead selectively sorted for degradation
by the ILF pathway. Two questions immediately arose after
making this exciting discovery: Is surface protein degradation by
the ILF pathway only triggered by toxic substrates, or does it
contribute to other triggers of surface transporter down-
regulation? Is the ILF pathway responsible for degradation of
other surface polytopic proteins? In other words, how pervasive is
the contribution of the ESCRT-independent ILF pathway to
surface transporter and receptor protein downregulation?
ILF pathway degrades Hxt3 in response to diverse stimuli.
When yeast cells are challenged with acute heat stress, surface
Fig. 1 Internalized transporter proteins take two routes to the vacuole lumen for degradation. a Cartoon illustrating how surface transporter proteins Can1
or Hxt3 are sorted for degradation by MVB or ILF pathways, respectively. b Micrographs of yeast treated with the toxin 2-deoxyglucose (top) or
canavanine (bottom) and stained with methylene blue to detect dead (MB+) cells indicated by white arrowheads. Graphs show relative number of dead
cells observed at increasing concentrations of either toxin. Means ± S.E.M. plotted. *P < 0.05, as compared to WT values by t-test. For 2-deoxyglucose
treatment, n= 3 experiments, whereby a total of 2355 WT, 2105 hxt3Δ, 1,786 vps27Δ and 1413 vps36Δ cells were analyzed. For canavanine treatment, n=
3 experiments whereby 2671 WT, 2033 can1Δ, 1647 vps27Δ and 1,538 vps36Δ cells were analyzed. c Micrographs showing route taken by Can1-GFP from
the surface to the vacuole lumen in response to 340.6 µM canavanine over 8 h in live wild type cells (right) or Hxt3-GFP in response to 0.2 mM 2-
deoxyglucose over 120min in live wild type (left) or vps36Δ (middle) cells. All cells were treated with FM4–64 to label vacuole membranes. Black
arrowheads indicate GFP on the vacuole membrane. d Three-dimensional GFP ﬂuorescence intensity (FI) plots and line plots of Can1-GFP (right), Hxt3-GFP
(middle, left) or FM4–64 ﬂuorescence intensity for micrographs with lines shown in c, to indicate vacuole membrane localization. Can1-GFP vacuole
distribution is shown at 6 h because intensity was too low at 4 h to generate informative plots. e Using micrographs shown in c, we calculated the
proportion of wild type or vps36Δ cells showing Can-GFP (right) or Hxt3-GFP (middle, left) ﬂuorescence on the plasma membrane (PM), intracellular
puncta, vacuole membrane (Vac mem) or vacuole lumen over time after treatment with canavanine or 2-deoxyglucose. For Hxt3-GFP at 0, 5, 30, 60, 120
min, n= 195, 198, 200, 207, 214 WT cells, and n= 202, 205, 207, 266, 211 vps36Δ cells analyzed. For Can1-GFP at 0, 2, 4, 6, 8 h, n= 207, 210, 246, 220,
208 WT cells analyzed. f Western blot analysis of whole-cell lysates prepared from wild type (left) or vps36Δ (middle) cells expressing Hxt3-GFP before
(0min) or 5–120min after treatment with 0.2 mM 2-deoxyglucose or wild-type cells expressing Can1-GFP before or after treatment with 340.6 µM
canavanine. Blots were stained for GFP or glucose-6-phosphate dehydrogenase (G6PDH; as load controls). Estimated molecular weights and cleaved GFP
band densities relative to 0min normalized to load controls are shown. Blots shown are representatives of n= 5 experiments. Scale bars, 1 µm
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Fig. 2 Hxt3-GFP is selectively degraded by the ILF pathway in response to 2-deoxyglucose. a Micrographs of live wild type cells expressing GFP-tagged
Hxt3 after treatment with 2-deoyglucose for 30min, or canavanine for 30min or 6 h. Vacuole membranes were stained with FM4–64. Arrowhead
indicates GFP on the vacuole membrane. b Line plots of GFP or FM4–64 ﬂuorescence intensity for lines shown in a and d, to indicate vacuole membrane
localization. GFP values greater than the FM4–64 signal at boundaries (near 2, for two membranes) indicate enrichment. c Using micrographic data
presented in a and d, we generated cumulative probability plots of GFP- tagged Hxt3, Fet5, Vph1 or Fth1 ﬂuorescence measured within the boundary
membrane of docked vacuoles within live wild-type cells in the absence or presence of 2-deoxyglucose (2DG). Averages ± S.E.M. are shown in insets. *P >
0.05, as compared to Vph1 by t-test. n= 3 experiments whereby 72 Vph1-GFP, 77 Fet5-GFP, 107 Fth1-GFP or 82 Hxt3-GFP+ 2DG boundaries within cells
were analyzed. d Micrographs of live wild type cells expressing GFP-tagged resident vacuole transporters Fet5, Vph1 or Fth1, or surface transporters Can1
or Itr1, before (control) after treatment with 2-deoxyglucose for 30min. Vacuole membranes were stained with FM4–64. e Using micrographs shown in
a and d, we calculated the proportion of wild type cells showing GFP ﬂuorescence on the plasma membrane (PM), intracellular puncta, vacuole membrane
(Vac Mem) or vacuole lumen (Vac Lumen) after treatment with 2-deoxyglucose or canavanine. For control conditions, n= 218 Hxt3-GFP, 187 Fet5-GFP,
265 Vph1-GFP, 267 Fth1-GFP, 233 Can1-GFP, and 189 Itr1-GFP cells. After 2-deoxyglucose treatment, n= 200 Hxt3-GFP, 143 Fet5-GFP, 128 Vph1-GFP, 161
Fth1-GFP, 150 Can1-GFP, and 178 Itr1-GFP cells. For canavanine treatment, n= 171 or 166 Hxt3-GFP cells after 0.5 or 6 h, respectively. f Images from time-
lapse video showing a homotypic vacuole fusion event within a live wild-type cell expressing Hxt3-GFP stained with FM4–64 to label vacuole membranes
and treated with 2-deoxyglucose. Arrowhead indicates newly formed ILF. See Supplementary Movie 1. g Analysis of micrographic data shown in f showing
the proportion of cells that displayed a vacuole fusion event within 5 min in the absence (CTL) or presence of 2-deoxyglucose (2DG). Averages ± S.E.M. are
shown. P > 0.05, when 2DG was compared to CTL by t-test. n= 5 experiments whereby a total of 121 (CTL) or 174 (2DG) Hxt3-GFP cells were analyzed.
Scale bars, 1 µm
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polytopic proteins are thought to misfold, which disrupts their
function and contributes to membrane permeabilization preced-
ing cell death. If they cannot be refolded (through the activity of
chaperones), they are internalized and sent to the vacuole lumen
for degradation—presumably by the MVB pathway—to mediate
surface polytopic protein quality control20.
Thus, to answer the ﬁrst question, we tested whether treating
cells with heat stress also triggers Hxt3-GFP degradation by the ILF
pathway using ﬂuorescence microscopy to monitor its distribution
within living cells. As with 2-deoxyglucose, we found that Hxt3-
GFP is internalized from the surface after heat stress and
accumulates on vacuole membranes (Fig. 3a, b) within boundaries
between docked organelles (Fig. 3a, c) and in the vacuole lumen
(Fig. 3d). We conﬁrmed that Hxt3-GFP decorated ILFs formed
during homotypic vacuole fusion events in live cells (Fig. 3e;
Supplementary Movie 2), which correlated with enhanced Hxt3-
GFP degradation as assessed by western blot analysis of whole-cell
lysates (Fig. 3f). Similar observations were made when we applied
cycloheximide (Fig. 4; Supplementary Movie 3), a trigger of TOR
(Target Of Rapamycin) signaling, an important mediator of cell
growth and metabolism44, that stimulates surface protein degrada-
tion17 and the ILF pathway37. Deleting VPS36 had no effect on
Hxt3-GFP clearance from plasma membranes, delivery to vacuole
boundary membranes, internalization during homotypic vacuole
fusion or protein degradation in response to heat stress (Fig. 3;
Supplementary Movie 4) or cycloheximide (Fig. 4; Supplementary
Movie 5), conﬁrming that this process is ESCRT-independent.






































































































































































































3.173.02    2.52   2.411.480.30
2.592.201.301.180.540.21
Fig. 3 Quality control of Hxt3-GFP is mediated by the ILF pathway. a Fluorescence and DIC micrographs of live wild type or vps36Δ cells expressing GFP-
tagged Hxt3 before (control) or after heat stress (37 °C for 15 min). Vacuole membranes were stained with FM4–64. Arrowheads indicate GFP on the
vacuole membrane. 3-dimensional GFP ﬂuorescence intensity (FI) plots and line plots of Hxt3-GFP or FM4–64 ﬂuorescence intensity for lines shown in
a, to indicate vacuole membrane localization after heat stress. bMicrographic data shown in a was used to calculate the proportion of wild type or vps36Δ
cells that show Hxt3-GFP ﬂuorescence on the plasma membrane (PM), intracellular puncta, vacuole membrane (Vac Mem) or vacuole lumen (Vac Lumen)
before or after treatment with heat stress. Under control (CTL) conditions, n= 218 WT cells or 243 vps36Δ cells under control conditions (CTL); n= 163
WT cells or 196 vps36Δ cells after heat stress. c, d Micrographic data shown in a was used to generate cumulative probability plots of Hxt3-GFP
ﬂuorescence measured within the boundary membrane (c) or lumen (d) of vacuoles within live wild type or vps36Δ cells before or after heat stress (HS).
GFP-tagged Fet5 (excluded), Vph1 (ubiquitous) and Fth1 (enriched) are shown for reference (see Fig. 2D). Averages ± S.E.M. are shown in insets. *P < 0.05,
as compared to Vph1 by t-test. n= 3 experiments whereby a total of 81 WT or 102 vps36Δ cells were analyzed under control conditions, and 75 WT or 88
vps36Δ cells were analyzed after heat stress. e Images from time-lapse videos showing homotypic vacuole fusion events within live wild type or vps36Δ cell
expressing Hxt3-GFP treated with heat stress. Vacuole membranes were stained with FM4–64. Arrowheads indicate newly formed ILFs. See
Supplementary Movies 2 and 4. Example shown is a representation of n= 4 experiments. fWestern blot analysis of whole-cell lysates prepared from wild-
type or vps36Δ cells expressing Hxt3-GFP after heat stress (HS) stained with anti-GFP antibody. Estimated molecular weights and cleaved GFP band
densities relative to CTL normalized to load controls (G6PDH) are shown. Blots shown are representatives of n= 3 experiments. Scale bars, 1 µm
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quality control and degrades this transporter protein in response to
cycloheximide.
ILF pathway machinery mediates Hxt3-GFP degradation
in vitro. To verify that the observed degradation of internalized
Hxt3-GFP was conducted by the ILF pathway machinery, we
repeated experiments using in vitro fusion reactions containing
isolated vacuoles based on the following reasoning [see 37]: (1) all
molecular machinery underlying the ILF pathway copuriﬁes with
vacuoles, in a preparation that excludes possible cytoplasmic
contributors to Hxt3-GFP degradation (e.g., the proteasome) as
well as the protein translation machinery to eliminate interference
by biosynthesis. (2) activation of the Rab GTPase Ypt7 is critical
for sorting proteins into the ILF pathway. However, deleting
YPT7 chronically blocks all vacuole fusion events including
MVB-vacuole fusion preventing study of the ILF and MVB
pathways in live cells. Instead, puriﬁed protein inhibitors of
Ypt7–rGdi1 (a Rab-GTPase chaperone protein that extracts Ypt7
from membranes) and rGyp1-46 (the catalytic domain of the Rab
GTPase activating protein Gyp1 that inactivates Ypt745) can be
added to in vitro vacuole fusion reactions containing healthy
organelles to acutely block Ypt7 permitting study of protein
sorting into ILFs. Thus, if the ILF machinery is responsible for
Hxt3-GFP degradation, then it should continue to occur in vitro
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Fig. 4 Cycloheximide triggers Hxt3-GFP degradation by the ILF pathway. a Fluorescence and DIC micrographs of live wild-type or vps36Δ cells expressing
GFP-tagged Hxt3 before (control) and after treatment with 100 µM cycloheximide for 45min. Vacuole membranes were stained with FM4–64.
Arrowheads indicate GFP on the vacuole membrane. Three-dimensional GFP ﬂuorescence intensity (FI) plots and line plots of Hxt3-GFP or FM4–64
ﬂuorescence intensity for lines shown in a, to indicate vacuole membrane localization after cycloheximide treatment. b Micrographic data shown in a was
used to calculate the proportion of wild type (n= 142) or vps36Δ (n= 158) cells that show Hxt3-GFP ﬂuorescence on the plasma membrane (PM),
intracellular puncta, vacuole membrane (Vac Mem) or vacuole lumen (Vac Lumen) after treatment with cycloheximide. Values before cycloheximide
treatment are shown for reference (see Fig. 3b). c, d Micrographic data shown in a was used to generate cumulative probability plots of Hxt3-GFP
ﬂuorescence measured within the boundary membrane (c) or lumen (d) of vacuoles within live wild-type or vps36Δ cells after treatment with
cycloheximide (CHX). GFP-tagged Fet5 (excluded), Vph1 (ubiquitous), and Fth1 (enriched; see Fig. 2d) and lumenal values before cycloheximide treatment
(see Fig. 3d) are shown for reference. Averages ± S.E.M. are shown in insets. *P < 0.05, as compared to Vph1 by t-test. n= 5 experiments whereby a total
of 73 wild type cells or 108 vps36Δ cells after CHX treatment were analyzed. e Images from time-lapse videos showing homotypic vacuole fusion events
within live wild type or vps36Δ cell expressing Hxt3-GFP treated with cycloheximide. Vacuole membranes were stained with FM4–64. Arrowheads indicate
initial fusion sites leading to ILF formation. See Supplementary Movies 3 and 5. Examples shown are representatives of n= 4 experiments. f Western blot
analysis of whole-cell lysates prepared from wild type or vps36Δ cells expressing Hxt3-GFP before (CTL) or after treatment with cycloheximide (CHX)
stained with anti-GFP antibody. Estimated molecular weights and cleaved GFP band densities relative to CTL normalized to load controls (G6PDH) are
shown. Blots shown are representatives of n= 4 experiments. Scale bars, 1 µm
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To test this hypothesis, we ﬁrst isolated vacuoles from
untreated wild-type cells, imaged them and found that Hxt3-
GFP decorated their membranes (Fig. 5a). Further investigation
revealed that surface Hxt3-GFP is down-regulated in live yeast
cells during the organelle isolation procedure (e.g., during
spheroplasting when their cell walls are enzymatically removed;
Fig. 5a). We made a similar observation when live cells were
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Fig. 5 The ILF pathway machinery is responsible for Hxt3-GFP degradation. a Fluorescence and DIC micrographs of live wild-type cells expressing GFP-
tagged Hxt3 before (untreated cells) and at stages of the vacuole isolation procedure, including after oxalyticase treatment to form spherophasts, after
DEAE-dextran treatment to permeabilize spheroplasts, and isolated vacuoles. Untreated cells in SC medium were also withdrawn from glucose for 5 min.
Vacuole membranes were stained with FM4–64. Micrographs shown are examples from n= 3 experiments. b Fluorescence micrographs of vacuoles
isolated from wild type (left) or vps36Δ (right) cells after 30min of fusion in the absence (CTL) or presence of heat stress (HS) or cycloheximide (CHX)
with or without fusion inhibitors (4 µM rGdi1 and 3.2 µM rGyp1–46; F.I.). Vacuole membranes were stained with FM4–64 and 3-dimensional ﬂuorescence
intensity (FI) plots of Hxt3-GFP are shown. Boundary membranes indicating Hxt3-GFP enrichment (closed arrowheads) and exclusion (open arrowheads)
are shown. c, d Micrographic data shown in b was used to generate cumulative probability plots of Hxt3-GFP ﬂuorescence measured within the boundary
membrane (c) or lumen (d) of vacuoles isolated from wild-type (top) or vps36Δ (bottom) cells before (CTL) and after treatment with HS or CHX with or
without fusion inhibitors (F.I.). Means ± S.E.M. are shown in insets. *P < 0.05, as compared to CTL by t-test. n= 3 experiments whereby a total of 113, 108,
120, 110, 108, 107 WT vacuoles or 133, 110, 128, 112, 116, 109 vps36Δ vacuoles were analyzed under CTL, CTL+ FI, HS, HS+ F.I., CHX, CHX+ F.I.
conditions, respectively. e Western blot analysis of Hxt3-GFP degradation before (0min) or after (120min) vacuoles isolated from wild type (top) or
vps36Δ (bottom) cells underwent fusion in the absence (CTL) or presence of HS (left) or CHX (right) with or without pretreatment with fusion inhibitors
(F.I.). Estimated molecular weights and cleaved GFP band densities (Dens.) relative to 0min normalized to load controls (Pho8) are shown.
Representatives of n= 4 experiments are shown. Scale bars, 2 µm
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novel trigger of Hxt3-GFP degradation. All solutions for the
organelle isolation procedure are devoid of glucose. Thus, we
reasoned that glucose depletion during vacuole puriﬁcation
triggers Hxt3-GFP downregulation, accounting for its presence
on vacuole membranes and within the lumen in vitro.
Next, we added ATP to isolated vacuoles to initiate homotypic
fusion in vitro and imaged reactions 30 min afterwards (Fig. 5b).
As expected, we found that Hxt3-GFP was present in boundary
membranes (Fig. 5c) and within the vacuole lumen (Fig. 5d).
Consistent with these ﬁndings, we found that more Hxt3-GFP
was degraded after fusion by western blot analysis (Fig. 5e).
However, we noted that relative high levels of cleaved GFP were
found in all preparations containing isolated vacuoles, including
those analyzed prior to fusion (0 min). It is possible that vacuole
rupture and release of lumenal proteases may account for this
observation. Although we cannot completely eliminate this
possibility, we argue that it is unlikely because protease inhibitors
are present in the fusion reaction buffer and should block all
extra-lumenal proteolysis. Moreover, this observation is consis-
tent with surface Hxt3-GFP being endocytosed and delivered to
the membrane and lumen of vacuoles during the isolation
procedure, prior to fusion in vitro (see Fig. 5a). This step of the
procedure requires 60 min, which may explain why band patterns
look similar to those observed at 60 min after 2-deoxyglucose
treatment in vivo (Fig. 1f). This also explains why relatively high
levels of lumenal GFP ﬂuorescence (~60% of total) are observed
in vacuole preparations prior to fusion (Fig. 6b). Thus, we are
conﬁdent that the observed changes in GFP-cleavage reﬂect
lumenal Hxt3-GFP degradation that correlates with
internalization during vacuole fusion, suggesting that the ILF
pathway mediates Hxt3-GFP degradation in vitro.
Importantly, both heat stress and CHX signiﬁcantly increased
the amount of Hxt3-GFP present in the boundary (Fig. 5b, c),
internalized (Fig. 5d) and degraded (Fig. 5e) by the ILF pathway
in vitro. We made similar observations when experiments were
repeated with vacuoles isolated from vps36Δ cells (Fig. 5b–e),
conﬁrming that ESCRTs are not required for protein sorting.
However, these responses were not as robust as those observed
in vivo (see Figs. 3 and 4). We reasoned that this is because Hxt3-
GFP found on isolated vacuole membranes is already marked for
degradation, as its presence is the product of downregulation
presumably triggered by glucose withdrawal during the organelle
isolation procedure (Fig. 5a) and it is degraded during fusion
in vitro under control (unstimulated) conditions (Fig. 5b–e).
Thus, heat stress or CHX further enhances clearance of Hxt3-
GFP that is already destined for degradation. Because these
responses are additive, we reasoned that heat stress and CHX
likely target distinct mechanisms, at least in part, from those that
respond to glucose withdrawal. Because heat stress and CHX
trigger Hxt3-GFP degradation in vitro, the underlying machinery
must be present on vacuole membranes, whereas the machinery
that senses glucose withdrawal must be, in part, present on the
plasma membrane to accommodate endocytosis, and neither
likely include ESCRTs.
Next, we pretreated in vitro vacuole fusion reactions with Ypt7
inhibitors and found that they blocked Hxt3-GFP sorting,
internalization and degradation (Fig. 5b–e), implicating Ypt7
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Fig. 6 Hxt3-GFP is cleared from vacuole membranes during fusion in vitro. a Fluorescence micrographs of vacuoles isolated from wild type cells expressing
Hxt3-GFP acquired over the course of the in vitro fusion reaction in the absence (control; left) or presence (right) of heat stress. Vacuole membranes were
stained with FM4–64. Scale bar, 2 µm. b, c Using micrographic data shown in a, averages ± S.E.M. of Hxt3-GFP ﬂuorescence intensity were measured
within the lumen (b) or outside membrane (c) of vacuoles isolated from wild-type cells over the course of the fusion reaction with or without heat stress.
*P < 0.05, as compared to CTL by t-test. n= 5 experiments whereby a total of 89, 88, 118, 100, 85 vacuoles were analyzed under CTL conditions, and 85,
108, 116, 110, 108 vacuoles were analyzed after HS, at 0, 30, 60, 90, 120min, respectively. d Line plots of Hxt3-GFP and FM4–64 ﬂuorescence, and 3-
dimensional GFP ﬂuorescence intensity (FI) plots of from micrographs in a showing vacuoles isolated from wild type cells before (0min) and after 120min
of fusion after heat stress, to indicate that Hxt3-GFP is completely cleared from vacuole membranes over time in vitro
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However, closer examination of western blots revealed that some
residual Hxt3-GFP cleavage occurred in the presence of inhibitors
under all conditions tested (Fig. 5e; compare 0–120 min with
fusion inhibitors). One explanation is that perhaps some vacuoles
were docked, and contained Hxt3-GFP in their boundary
membranes, upon isolation (i.e., they were engaged in the fusion
process in live cells before lysis). If so, then Ypt7 inhibitors would
be unable to block subsequent Ypt7-independent stages of fusion
responsible for Hxt3-GFP internalization and degradation,
accounting for the observed residual GFP-cleavage. This also
accounts for the small fraction of the vacuole population that
contains relatively high levels of Hxt3-GFP ﬂuorescence in
the boundary and lumen in the presence of Ypt7 inhibitors
(Fig. 5c, d). Thus, all things considered, we are conﬁdent that
Ypt7 and the ILF pathway machinery located on the vacuole
membrane is likely responsible for Hxt3-GFP degradation
triggered by diverse stimuli.
Clearance of ESCRT-client proteins from endosome mem-
branes is thought to require multiple rounds of ILV formation3,
raising the question: How efﬁcient is protein clearance from
vacuole membranes by the ILF pathway? To answer it, we
initiated homotypic vacuole fusion in vitro with ATP and imaged
reactions every 30 min over 2 h (Fig. 6a). Some GFP ﬂuorescence
was observed in the vacuole lumen prior to fusion (0 min) and
this signal increased over the course of the fusion reaction
(Fig. 6b). Moreover, the amount of Hxt3-GFP on vacuole
membranes decreased over time (Fig. 6c), conﬁrming that this
transporter was getting internalized into the lumen during the
fusion reaction. Similar observations were made after isolated
vacuole were subjected to heat stress prior to initiation of fusion
(Fig. 6a–c), except the effect was more pronounced whereby
nearly all of Hxt3-GFP on the membrane was internalized into
the lumen after 120 min (also see Fig. 6d), consistent with
complete degradation observed by western blot analysis (Fig. 5e).
Previously, we showed that heat stress has no effect on the rate of
vacuole fusion in vitro37 and it is known that the population of
isolated vacuoles undergoes 1.5 fusion events after 120 min under
these conditions46. Thus, we estimate that Hxt3-GFP can be
completely cleared from vacuole membranes within two fusion
events.
ILF pathway mediates quality control of many surface proteins.
Is the ILF pathway responsible for downregulation of other sur-
face transporter proteins? To answer this (second) question, we
used ﬂuorescence microscopy to screen for other ILF-client
proteins by examining the intracellular membrane distribution of
GFP-tagged surface transporter or receptor proteins after live
cells were challenged with heat stress, which should trigger
degradation of all surface polytopic proteins. Five surface proteins
showed clear phenotypes: Unlike Can1, Ste3 (a G-protein coupled
receptor) or Mup1 (a methionine permease [see 47]), internalized
GFP-tagged Itr1 (a myo-inositol transporter)40 and Aqr1 (a
major facilitator superfamily-type transporter that excretes amino
acids)48 appeared on vacuole membranes on route to the vacuole
lumen for degradation (Fig. 7a, c). Both transporters were present
within boundary membranes between organelles (Fig. 7b) and
accumulated in the vacuole lumen of live wild type cells after heat
stress (Fig. 7d). This correlated with enhanced Itr1-GFP and
Aqr1-GFP degradation after heat stress as assessed by western
blot analysis of whole-cell lysates (Fig. 7e). Importantly, deleting
VPS27, a component of ESCRT-0, had no effect on the, inter-
nalization, sorting or degradation of Itr1-GFP or Aqr1-GFP after
heat stress (Fig. 7a–e), conﬁrming that the ESCRT-independent
ILF pathway is critical for quality control of these transporter
proteins. Thus, the ILF pathway mediated degradation of three of
six proteins examined, suggesting that it may play a considerable
role in surface transporter protein downregulation.
Discussion
Here we demonstrate that whereas some internalized surface
polytopic proteins (Can1) rely on the canonical ESCRT-
dependent MVB pathway for downregulation, other presumed
ESCRT-client proteins (Hxt3, Itr1, Aqr1) bypass ESCRT function
at endosomes and, upon MVB-vacuole fusion, are delivered to
vacuole membranes where they are selectively sorted for degra-
dation by the ILF pathway (see Fig. 1a). Both pathways are
triggered by the presence of toxic substrates, substrate withdrawal
or cycloheximide and are critical for protein quality control.
Thus, the assumption that all surface proteins are degraded by the
MVB pathway is no longer reasonable, and we speculate that the
ILF pathway may play an equally important role in surface
polytopic protein downregulation. This conclusion raises many
new questions concerning this important area of fundamental cell
biology: What evidence supports ESCRT-mediated protein down-
regulation? What distinguishes one pathway from the other?
What determines protein entry into each pathway? What is the
potential impact of this discovery on eukaryotic physiology?
Herein, we reveal that internalized surface polytopic proteins
may take two distinct pathways to the vacuole lumen for degra-
dation. Paramount to this discovery was visualizing internalized
surface receptors within live cells over time to track their routes to
the vacuole lumen for degradation (e.g., Figure 1c). This revealed
that some internalized proteins accumulate on the vacuole
membrane: a trafﬁcking intermediate that does not occur in the
MVB pathway, but is a requirement for the ILF pathway.
Unfortunately, the majority of previous reports on surface protein
degradation do not provide such detailed kinetic analyses and
instead present only light micrographs of cells before and after
treatment, indicating surface and vacuole lumen protein dis-
tributions respectively13,14,41,49–52. Many important papers ori-
ginally describing degradation of surface receptors or transporters
do not include any micrographs53. Thus, the pathway responsible
for their degradation now seems enigmatic. Moreover, when
comprehensive datasets are provided, many internalized surface
transporters appear on vacuole membranes38, suggesting that
ILF-dependent degradation of surface proteins may be
widespread.
Further confounding this issue is that protein sorting and ILV
formation by ESCRTs cannot be accurately visualized in biolo-
gical systems using light microscopy due to limitations of spatial
resolution. Rather, samples must be ﬁxed and imaged using
electron microscopy coupled with immune-gold labeling. Due to
associated technical challenges, very few reports provide electron
micrographs to deﬁnitively demonstrate protein sorting or
internalization by ESCRTs54–56. However, for the ILF pathway,
here we show surface transporters being delivered to the lumen
during homotypic vacuole fusion in real time within live cells
using HILO microscopy (Figs. 2f, 3e, and 4e; Supplementary
Movies 1–5). In addition to providing deﬁnitive proof that the
ILF pathway contributes to degradation of these transporters, this
approach (including FRAP37) offers the advantage of allowing us
to study the fundamental properties of protein sorting for
transporter and receptor downregulation.
Finally, although we present data from complimentary
experimental approaches to support our conclusions, we recog-
nize that both pathways rely on the same membrane trafﬁcking
route within cells, i.e. endocytosis culminating with MVB-vacuole
fusion (see Fig. 1a). As such, we expect that genetic manipulations
affecting both pathways will cause pleiotropic phenotypes. For
example, in addition to blocking ILV formation, deleting ESCRT
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genes partially inhibits MVB-vacuole fusion57, which is required
to deliver internalized proteins to the ILF pathway, and prevents
efﬁcient delivery of some biosynthetic cargoes to the vacuole
lumen (e.g., carboxypeptidase S and other vacuole hydrolases)3.
This perhaps explains why Hxt3-GFP accumulates on puncta and
the vacuole membrane in vps36Δ cells (e.g., Fig. 1c–e) and its
degradation proﬁle is different than in wild-type cells (Figs. 1f, 3f,
4f, 5e, and 7e). If true, then appearance of internalized proteins on
these aberrant structures in ESCRT knockout cells is not a phe-
notype exclusive to ESCRT-client proteins, warranting reevalua-
tion of published data that relies on this phenotype to infer
protein degradation by the MVB pathway. All things considered,
we provide a logical framework to determine which pathway
mediates surface protein degradation and are currently con-
ducting screens to comprehensively understand the contributions
of each to surface receptor and transporter down-regulation in S.
cerevisiae.
From a mechanistic perspective, both pathways are processes
that share four general stages required for selective protein
degradation:3,37 (1, labeling) The protein must be labeled for
degradation. (2, sorting) Labeled proteins must be selectively
sorted into an area of membrane that is (3, internalization)
internalized as a vesicle (or membrane fragment) into the lumen
of an endocytic organelle. (4, degradation) Protein-laden lumenal
vesicles must be exposed to vacuolar hydrolases for catabolism.
Given these functional similarities, we argue that the underlying
molecular machinery must, in part, be shared by both pathways.
However, it must also differ to account for their distinctions.
Although little is known about protein labeling in the ILF



































































































































































































































Fig. 7 Quality control of surface transporters Itr1 and Aqr1 is mediated by the ILF pathway. a Fluorescence and DIC micrographs of live wild type (top) and
vps27Δ (bottom) cells expressing GFP-tagged Hxt3, Itr1, Aqr1, Ste3, or Mup1 before (control) and after heat stress (37 °C for 15 min). Vacuole membranes
were stained with FM4–64. Arrowheads indicate GFP on the vacuole membrane. Scale bar, 1 µm. b Three-dimensional GFP ﬂuorescence intensity (FI) plots
and line plots (left) of GFP or FM4–64 ﬂuorescence intensity for lines shown in a to indicate boundary membrane localization after heat stress. c, d Using
micrographic data shown in a, we measured the proportion of wild type or vps27Δ cells with GFP ﬂuorescence observed on the vacuole membrane (c) or
within the lumen (d) before (CTL) or after heat stress. Averages ± S.E.M. are shown. *P < 0.05, as compared to CTL by t-test. n= 4 experiments whereby a
total of 238 Hxt3-GFP cells, 180 Itr1-GFP cells, 180 Aqr1-GFP cells were analyzed under CTL conditions, and 222 Hxt3-GFP cells, 161 Itr1-GFP, 167 Aqr1-GFP
cells were analyzed after HS. eWestern blot analysis of whole-cell lysates prepared from wild type or vps27Δ cells expressing Itr1-GFP or Aqr1-GFP before
(CTL) or after heat stress (HS) stained with anti-GFP antibody. Estimated molecular weights and cleaved GFP band densities (Dens.) relative to CTL
normalized to load controls (G6PDH) are shown. Blots are representatives of n= 3 experiments
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shared with the MVB pathway, which employs protein ubiquity-
lation as a label for selective degradation58. This is based on the
following reasoning: (1) prior to this work, Hxt3, Itr1 and Aqr1
were reported to be ubiquitylated by speciﬁc E3-ligase and E4-
adapter proteins in response to the same stimuli that drive their
downregulation by the ILF pathway (e.g., Rsp5 and Art5, respec-
tively, for Itr1)40. 2 The same ubiquitylation machinery labels
polytopic proteins at the plasma membrane, endosome membranes,
and vacuole membranes (e.g., E3 ligases Rsp5 and Pib1, and E4
adapter Ssh4)40,43,59. This possibly explains why heat stress triggers
degradation of Hxt3-GFP on isolated vacuole membranes in vitro
(Figs. 5 and 6), as is does for Hxt3-GFP on the plasma membrane in
live cells (Figs. 3 and 7). 3 When ESCRT genes are deleted, ESCRT-
client proteins Can1, Ste3, and Mup1 continue to be degraded,
albeit less efﬁciently, by the ILF pathway47, suggesting that the
machinery underlying sorting in each pathway recognizes a com-
mon label. Furthermore, the ubiquitylation machinery mediates
selective soluble protein degradation by other cellular pathways
(e.g., Rsp5, Ydj1, and the proteasome)60. Sharing the same sensing
and labeling machinery permits harmonization of protein degra-
dation pathways, including the ILF and MVB pathways, for coor-
dinated compartmental changes in proteostasis needed for a global
cellular response to a single stimulus and this redundancy also
ensures toxic proteins are destroyed.
It is clear from this study that the mechanisms underlying
protein sorting into each pathway are distinct: ESCRTs drive
sorting in the MVB pathway3,58, an unknown, ESCRT-
independent mechanism that requires Rab-GTPase activation is
important for sorting in the ILF pathway (Fig. 5) [see 37]. Loca-
tion of the sorting machinery is not likely critical, as ESCRTs are
found on endosome and vacuole membranes43, and the
machinery thought to underlie protein sorting into ILFs is present
on endosome and vacuole membranes where they drive fusion
events (e.g., Ypt7)57,61. The mechanisms underlying internaliza-
tion are distinct as well: In the MVB pathway, labeled proteins are
internalized by ILV formation culminating with lipid bilayer
scission by ESCRT-III and the Vps4-Vta1 complex on the
endosome membrane62. Whereas, labeled proteins are inter-
nalized by ILF formation during bilayer fusion by fusogenic
proteins (SNAREs) and lipids concentrated at the vertex ring
formed between two docked vacuoles33–35,37. Finally, the
mechanisms underlying degradation are essentially shared as the
outcomes of both processes are equal: polytopic proteins
embedded in membrane vesicles (or fragments) are degraded by
acid hydrolases with the vacuole lumen3,37.
In terms of efﬁciency, each ILV generated by ESCRTs has an
estimated membrane area of 0.03µm2 (assuming it is spherical
with a radius of 0.05 µm63) whereas each ILF generated by a
vacuole fusion event has an area up to 2.26 µm2 (assuming it is a
double boundary membrane disk with a radius of 0.6µm, average
vacuole radius of 1.0 µm, and all of the boundary membrane is
internalized)36. Thus, membrane internalized by a single ILF is
equivalent to 75 ILVs. Given that each MVB contains approxi-
mately 30 ILVs63, at least three MVB-vacuole fusion events are
necessary to deliver the same amount of protein-laden membrane
to the vacuole lumen as a ILF produced by one vacuole fusion
event. Herein, we also show that nearly all Hxt3-GFP is cleared
from vacuole membranes by the ILF pathway within two rounds
of vacuole fusion in vitro (Fig. 6). In live cells, individual vacuole
fusion events require 30–60 s (e.g., Fig. 2f and Supplementary
Movie 1) under conditions that promote Hxt3-GFP enrichment
within boundary membranes (Fig. 2c). Endocytosis can occur
within min64. Thus, when considering the capacity and kinetics of
this process, it is easy to envision how the ILF pathway can
completely down-regulate Hxt3 in as little as 5 min, as observed
after glucose withdrawal (Fig. 5a). Furthermore, this possibly
accounts for faster delivery of the ILF-client Hxt3-GFP from the
surface to the vacuole lumen as compared to the ESCRT-client
Can1-GFP observed in response to their cognate toxins within
live cells (Fig. 1e). In all, it seems that the ILF pathway offers the
cell a relatively high-capacity solution for rapid surface polytopic
protein degradation.
Surface receptor and transporter protein downregulation is
critical for diverse physiology in all eukaryotes. ESCRT-
dependence has been demonstrated for only a handful of
human receptors and transporters. These represent a miniscule
fraction of an estimated ~5500 polytopic proteins encoded by
the human genome65, all of which presumably have ﬁnite
lifetimes and must be selectively degraded. Thus, for the subset
that represents surface polytopic proteins, it is reasonable to
propose that this burden is split by at least two pathways. For
example, here we discovered that the ILF pathway mediates
downregulation of the yeast hexose transporter (Hxt3) when
glucose is withdrawn from the growth medium (Fig. 5a).
Downregulation of orthologous glucose transporters (e.g.,
GLUT4) triggered by glucose depletion is observed in mam-
malian epithelial cells lining the ileum or proximal tubule of the
nephron66–68, but it is not clear what mediates this process,
which is needed for sugar (re)absorption. Genes encoding the
proposed machinery underlying the ILF pathway are conserved
in all eukaryotes including humans69, like genes encoding
ESCRTs3. Thus, it is tempting to speculate that the ILF pathway
also contributes to the down-regulation of these sugar trans-
porters, as well as other receptors and transporters, in mam-
malian cells.
Why two pathways? Evolutionary theory predicts that each
pathway must perform a distinct, fundamental function
necessary for eukaryotic physiology to be conserved. The con-
cept of two pathways for surface polytopic protein down-
regulation is obviously still in its infancy, but in support, we
offer three speculative explanations for their coexistence: (1)
whereas, the function of ESCRT clients, such as Can1, may be
unnecessary or not tolerated on vacuole membranes, ILF-client
proteins may function on vacuoles (or lysosomes) as well as on
the plasma membrane. However, this is unlikely for Hxt3
because after it is endocytosed, it concentrates in boundary
membranes (Figs. 2c, 3c, 4c, and 5c) and is efﬁciently cleared
from vacuole membranes (see Fig. 6). (2) Unlike ILF clients,
ESCRT-client proteins may require immediate sequestration
from the cytoplasm after endocytosis. For example, activated
hormone receptors must be sequestered into ILVs for accurate
signal termination8. (3) ESCRT clients are can be reused either
by ILV back fusion, i.e., membrane fusion between ILV and
MVB perimeter membranes (although this is contentious) or by
MVB-plasma membrane fusion which releases protein-laden
ILVs as exosomes8. Whereas degradation is certain for ILF-
client proteins.
In addition to their role in the MVB pathway, ESCRTs are
recruited to other compartmental membranes where they make
important contributions to cytokinesis, reformation of the
nuclear envelope, and exosome release—process that terminate
with membrane ﬁssion70,71. Orthologous components of the ILF
machinery (e.g., CORVET) are present on other endosomal
compartments where it drives fusion events needed for mem-
brane trafﬁcking as well as organelle biogenesis and
homeostasis61,69. Thus, from a broader perspective, it seems that
ESCRTs drive membrane remodeling prior to ﬁssion, whereas the
components of the ILF pathway remodel membranes prior to
fusion within eukaryotic cells. Through these different mechan-
isms, we speculate that the ILF pathway plays a distinct but
equally important role as the MVB pathway in surface transporter
and receptor downregulation.
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Methods
Yeast strains and reagents. All Saccharomyces cerevisiae strains used in this
study are listed in Table 1. All unique yeast strains generated for this study are
available from the authors. To knock out VPS27 by homologous recombination we
used the Longtine method72 and the following primers: (forward; CBO202) 5′-
GCTAAGGTGAATGAGTAGTGAGTAAAGAACTAAGAACAGTCGGAT
CCCCGGGTTAATTAA-3′ and (reverse; CBO203) 5′-CTAGGTTCCTTTTTA
CAAATACATAG AAAAGGCTACAATAGAATTCGAGCTCGTTTAAAC-3′;
and extended the homologous regions of genomic DNA (underlined) covering 80
base pairs to improve targeting and integration using the following primer set:
(forward; CBO204) 5′-TAGAGGGTGTAAAATTATCAAG ATTTTTTTTTGC
TAAGGTGAATGAGTAGTC-3′ and (reverse; CBO205) 5′-CAAGCAATTA
TATA TATATGTATGTATATATTTATAAGCGCTAGGTTTCTTTTTA
CAAAT-3′. To knockout VPS36, we used the same approach with the following
primer sets: (forward, CBO594) 5′-AGGAAGTG TGTTTTGAAAGTCATTCT
TTTTTTTTCAAAAGCGGATCCCCGGGTTAATTAA-3′ and (reverse; CBO596)
5′-ATGTAGTATTACGAGCAGGTAATCAAACCATGCATTTATTGAATTC
GAGCTCGTT TAAAC-3′, as well as (forward, CBO595) 5′-AGGTCATCCAAG
ATAGAATAGGGGACC TCGGCTAGGAATCAGGAAGTGTGTTTTGAAAGT-
3′ and (reverse; CBO597) 5′-TTTAGCC GCGCGTTTATATGTAAACTATTTA
TTTGGGAGAATGTAGTATTACGAGCAGGT-3′. Genomic mutations were
conﬁrmed by PCR and sequencing.
Biochemical and yeast growth reagents were purchased from either Sigma-
Aldrich, Invitrogen, or BioShop Canada Inc. Proteins used include recombinant
Gdi1 puriﬁed from bacterial cells using a calmodulin-binding peptide intein fusion
system73 and recombinant Gyp1–46 (the catalytic domain of the Rab-GTPase
activating protein Gyp1) puriﬁed as previously described74. Reagents used in fusion
reactions were prepared in 20 mM Pipes-KOH, pH 6.8, and 200 mM sorbitol (Pipes
Sorbitol buffer, PS).
Yeast cell viability assay. To assess cell viability, yeast were cultured in SC
medium for 16–18 h, pelleted, and resuspended in fresh SC medium. Cells were
then treated with 0, 0.2 or 2 mM 2-deoxyglucose and incubated at 30 °C for 2 h, or
with 0, 37, or 340.6 µM canavanine and incubated at 30 °C for 8 h. After incuba-
tion, cells were washed once with SC medium, resuspended in 100 µL SC con-
taining 0.1% (w/v) methylene blue and incubated at room temperature for 5 min
prior to imaging. Micrographs were acquired using a Nikon Eclipse TiE inverted
epiﬂuorescence microscope equipped with a Nikon DsRi2 high resolution
(4908 × 3264 pixels) color CMOS (Complementary Metal-Oxide Semiconductor)
camera, a Nikon CFI × 40 Plan Apo Lambda 0.95 NA objective lens and DIC
optics. Methylene blue positive (MB+ ) and unstained cells were counted manually
using ImageJ software (National Institutes of Health, USA).
Highly inclined laminated optical sheet (HILO) microscopy. Micrographs were
acquired using a Nikon Eclipse TiE inverted microscope equipped with a motor-
ized TIRF (Total Internal Reﬂection Fluorescence) illumination unit, Photometrics
Evolve 512 EMCCD (Electron Multiplying Charge Coupled Device) camera, Nikon
CFI ApoTIRF 1.49 NA ×100 objective lens, and 488 nm or 561 nm 50 mW solid-
state lasers operated with Nikon Elements software. Cross sectional images were
recorded 1 μm into the sample.
Live cell imaging. Live yeast cells were stained with FM4–64 to label vacuole
membranes using a pulse-chase method as previously described45. To trigger
downregulation of GFP-tagged surface polytopic proteins, cells in SC medium were
either treated with 0.2 mM 2-deoxyglucose (Sigma-Aldrich) for up to 120 min at
30 °C, 340.6 μM canavanine (Sigma-Aldrich) for up to 8 h at 30 °C, 100 μM
cycloheximide for 90 min at 30 °C, resuspended in SC medium without D-glucose
for 5 min at 30 °˚C, or incubated at 37 °C for 15 min for heat stress. After treat-
ments, cells were washed and resuspended in SC medium at 30 °C prior to imaging
by HILO microscopy. Time-lapse videos were acquired for 5 min at 30 °C using a
Chamlide TC-N incubator (Live Cell Instruments) with cells plated on coverslips
coated with concavalin-A (1 mg/mL in 50 mM HEPES, pH 7.5, 20 mM calcium
acetate, 1 mM MnSO4).
Vacuole isolation and homotypic vacuole fusion. Vacuoles were puriﬁed from
yeast cells as previously described75, whereby cells were harvested, washed, treated
with oxalyticase to generate spheroplasts (shown Fig. 5a), gently permeabilized
using DEAE-dextran (also shown in Fig. 5a) and then organelles were separated on
a ﬁcoll gradient by ultracentrifugation (100,000 × g, 90 min, 4 °C). Homotypic
vacuole fusion reactions were prepared using 6 μg of isolated vacuoles in standard
fusion reaction buffer with 0.125 M KCl, 5 mM MgCl2, and 10 μM CoA. 1 mM
ATP was added to trigger fusion. Vacuolar membranes were stained with 3 μM
FM4–64 for 10 min at 27 °C. Reactions were incubated at 27 °˚C for up to 120 min
and placed on ice prior to visualization by HILO microscopy. Where indicated,
vacuoles were incubated in the absence or presence of the fusion inhibitors 3.2 μM
Gyp1–46 and 4 μM rGdi. For heat stress or cycloheximide treatment, isolated
vacuoles were incubated at 37 °C for 5 min or at 27 °C with 100 µM cycloheximide
for 15 min, respectively, prior to adding them to the fusion reaction.
Western blot analysis. For analysis of whole-cell lysates, yeast cells were prepared
as previously described76. In brief, extracts were prepared by harvesting yeast cells
grown in culture to mid-log phase and washing them once with YPD medium.
Cells were then resuspended in fresh YPD and incubated at 30 °C in the presence of
0.2 mM 2-deoxyglucose or 340.6 μM canavanine for times indicated in Fig. 1f, at
30 °C for 90 min for control conditions, at 30 °C in the presence of 100 μM
cycloheximide for 120 min, or incubated at 37 °C for 90 min for heat stress. After
treatment, 5 OD600nm units of cells were collected, resuspended in 0.5 mL of lysis
buffer (0.2 M NaOH, 0.2% β-mercaptoethanol) and incubated on ice for 10 min.
Trichloroacetic acid was then added to a ﬁnal concentration of 5% and samples
were incubated on ice for an additional 10 min. Precipitates were collected by
centrifugation (12,000 × g for 5 min at 4 °C) and resuspended in 35 μL of dis-
sociation buffer (4% SDS, 0.1 M Tris-HCl, pH 6.8, 4 mM EDTA, 20% glycerol, 2%
β-mercaptoethanol and 0.02% bromophenol blue). Tris-HCl, pH 6.8 was then
added to a ﬁnal concentration of 0.3 M and samples were incubated at 37 °C for 10
min. For analysis of in vitro fusion reactions, samples were prepared from isolated
vacuoles as previously described37. Whole-cell lysates or isolated vacuole pre-
parations were loaded into 10% SDS-polyacrylamide gels and after electrophoresis
separated proteins were transferred to nitrocellulose membranes. Membranes were
then probed with antibodies raised against GFP (1:1,000; B2, Santa Cruz Bio-
technology Inc., Cat# sc-9996; or Abcam, Cat# ab290), G6PDH (1:1000; Sigma-
Aldrich, Cat# A9521) or Pho8 (1:1000; 1D3A10, Abcam, Cat# ab113688). Horse-
radish peroxidase-labeled afﬁnity puriﬁed polyclonal antibodies to either rabbit or
mouse (1:10,000; SeraCare, Cat# 5450-0010 or 5450-0011) were used for secondary
labeling. Please refer to manufacturer’s website for antibody validation. Chemilu-
minescence of stained membranes was digitally imaged using a GE Amersham
Imager 600.
Data analysis and presentation. Micrographs and movies were processed using
ImageJ and Adobe Photoshop CC software. Images shown were adjusted for
brightness and contrast, inverted and sharpened with an unsharp masking ﬁlter.
Linear or 3-dimnesional ﬂuorescence intensity proﬁles of GFP or FM4–64 ﬂuor-
escence were generated using ImageJ software. Snapshots from movies were
selected to highlight docking and ILF formation during vacuole fusion. Group
allocations were blinded for all micrographic analysis.
GFP location measurements shown in Figs. 1e, 2e, 3b, 4b, 7c, d were generated
using the ImageJ Cell Counter plugin. Micrographs were quantiﬁed by counting the
total number of cells, as well as the number of cells where the GFP ﬂuorescence was
detected on the plasma membrane (PM), intracellular puncta, the vacuole
membrane (Vac mem), or in the vacuole lumen. Values for each cellular GFP
localization were normalized to the total number of cells. In Fig. 2g, movies vacuole
fusion events in vivo were used to determine the percent of fusion events; Only
cells containing two or more vacuoles were counted.
Relative vacuole boundary, lumenal or outside membrane GFP ﬂuorescence
values were measured using ImageJ software [see 37]. Prior to quantiﬁcation,
micrographs were background subtracted and a 4 × 4 pixel region of interest was
then used to measure the mean GFP ﬂuorescence within the boundary, lumen or
on the outer membrane of docked vacuoles only. Single vacuoles or docked
vacuoles without a clear outer membrane (i.e., those in large clusters) were
excluded. Mean GFP ﬂuorescence intensity was correlated to vacuole size
(boundary length, surface area or circumference) by measuring the vacuole
Table 1 Yeast strains used in this study
Strain Genotype Source
BY4741 MATα his3-Δ1 leu2-Δ0 met15-Δ0 ura3-
Δ0
77
Can1-GFP BY4741, Can1-GFP::HIS3MX 77
Ste3-GFP SEY6210, Ste3-GFP::KanMX 78
Mup1-GFP SEY6210, Mup1-GFP::KanMX 78
Hxt3-GFP BY4741, Hxt3-GFP::His3MX 77
Hxt3-GFP:vps36Δ BY4741, Hxt3-GFP::His3MX, vps36Δ:
KanMX
This study
Hxt3-GFP:vps27Δ BY4741, Hxt3-GFP::His3MX, vps27Δ:
KanMX
This study
Itr1-GFP BY4741, Itr1-GFP::His3MX 77
Itr1-GFP:vps27Δ BY4741, Itr1-GFP::His3MX, vps27Δ:
KanMX
This study
Aqr1-GFP BY4741, Aqr1-GFP::His3MX 77
Aqr1-GFP:vps27Δ BY4741, Aqr1-GFP::His3MX, vps27Δ:
KanMX
This study
Fet5-GFP BY4741, Fet5-GFP::HIS3MX 77
Fth1-GFP BY4741, Fth1-GFP::HIS3MX 77
Vph1-GFP BY4741, Vph1-GFP::HIS3MX 77
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diameter (average of two lengthwise measurements) and the length of the
boundary membrane. Boundary GFP ﬂuorescence is normalized to that of the
outer membrane and lumenal GFP ﬂuorescence is normalized to total ﬂuorescence
(boundary, outer membrane and lumen). Only cells containing clearly resolved
docked vacuole membranes were used for micrographic analysis.
When applicable, data are reported as cumulative probability plots as well as
mean ± S.E.M. Comparisons were calculated using Student two-tailed t-test; P
values < 0.05 (*) indicate signiﬁcant differences. An experiment is deﬁned as a
sample prepared from a separate yeast culture on different days. The total number
of cells, vacuoles, or boundaries analyzed are indicated. Samples sizes were tested to
ensure adequate power using online software (http://www.biomath.info). Variance
was assumed to be similar between groups compared. Data was plotted using
Synergy KaleidaGraph 4.0 software and ﬁgures were prepared using Adobe
Illustrator CC software.
Data availability
Data that support ﬁndings of this study are available from the corresponding
author upon reasonable request.
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